# US 2008/0305348 A1 · Solid State Membranes with Surface-Embedded Glycosylated Amphiphilic Molecules and Micelles Formed Therefrom

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0305348 A1
- Document ID: US20080305348A1
- Status: Published application
- Kind: A1
- Application number: 11/761,045
- Filed: 2007-06-11
- Published: 2008-12-11
- Earliest claimed: 2007-06-11
- Inventors: Richard H. Spedden
- Web page: https://patentgrep.com/patent/US20080305348A1

## CPC

- G01N 33/5432: {Liposomes or microcapsules}
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 29/16: Biologically active materials, e.g. therapeutic substances {(A61L29/048 takes precedence)}
- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- C08L 1/02: Cellulose; Modified cellulose
- C08L 5/04: Alginic acid; Derivatives thereof
- C08L 91/06: Waxes
- A61L 2300/232: Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
- C08L 89/00: Compositions of proteins; Compositions of derivatives thereof
- Y10T 428/31504: Composite [nonstructural laminate]
- Y10T 428/31844: Of natural gum, rosin, natural oil or lac
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

Disclosed herein are glycosylated amphiphilic molecules composed of hydrophobic “tails” and hydrophilic “heads” that self align to form a membrane at the interface of a polar solvent and a non-polar liquid or a solid. The present invention is directed to a solid state membrane, typically a thin film, composed of a non-polar solid material having the hydrophobic “tail” of a glycosylated amphiphilic molecule embedded in or linked to its surface such that the hydrophilic “head” protrudes from the solid surface and presents useful properties to the surrounding environment. A membrane or film in accordance with the present invention is produced when a non-polar liquid, in the presence of a polar solvent and an amphiphilic biological compound, undergoes a transformation from liquid to solid, through thermal, chemical or radiative means, with the resultant effect that the amphiphilic molecule is affixed or “locked” to the surface, more particularly the hydrophobic ends of the amphiphilic compounds are mechanically or chemically linked to or embedded in the non-polar solid. The membrane and micelles produced therefrom remain stable even in the absence of the polar solvent, thereby allowing the hydrophilic components of the amphiphilic compounds to present useful properties at the surface thereof.

## Claims

### Claim 1

A solid state film having at least one functionally active surface, said film comprising a non-polar substrate having upper and lower surfaces, said substrate having affixed thereto a plurality of glycosylated amphiphilic molecules, each of which comprise a hydrophobic tail end and a hydrophilic head end provided with one or more functional groups, wherein the hydrophobic tail ends are embedded in or chemically or mechanically linked to the upper surface of said non-polar substrate and the functional groups of the hydrophilic tail ends project from said upper surface so as to provide at least one surface of said film with functional activity.

### Claim 2 (depends on 1)

The solid state film of claim 1, wherein said glycosylated amphiphilic molecules are selected from the group consisting of glycoproteins, glycolipids, glycosides, and combinations thereof.

### Claim 3 (depends on 2)

The solid state film of claim 2, wherein at least one of said glycosylated amphiphilic molecules is a glycoprotein.

### Claim 4 (depends on 3)

The solid state film of claim 3, wherein said glycoprotein is selected from the group consisting of ovotransferrin, ovalbumin, ovomucoid, glycophorin, mucoproteins, lectins, immunoglobulins, hormones, and proteoglycans.

### Claim 5 (depends on 3)

The solid state film of claim 3, wherein said glycoprotein comprises an N-linked oligosaccharide.

### Claim 6 (depends on 1)

The solid state film of claim 1, wherein at least one of said glycosylated amphiphilic molecules is a glycoside selected from the group consisting of chitin, chitosan, cellulose, saponin, and derivatives thereof.

### Claim 7 (depends on 1)

The solid state film of claim 1, wherein at least one of said glycosylated amphiphilic molecules comprises a synthetic moiety or a block copolymer.

### Claim 8 (depends on 1)

The solid state film of claim 1, wherein said non-polar substrate is selected from the group consisting of resin, natural and synthetic wax, natural and synthetic plastics, fats, polymers or hydrocarbon mixtures.

### Claim 9 (depends on 1)

The solid state film of claim 1, wherein said non-polar substrate is a natural wax selected from the group consisting of animal, vegetable and mineral waxes and derivatives thereof.

### Claim 10 (depends on 1)

The solid state film of claim 1, wherein said non-polar substrate is a thermoplastic polymer.

### Claim 11 (depends on 10)

The solid state film of claim 10, wherein said thermoplastic polymer is a low density polyethylene or a vinyl copolymer.

### Claim 12 (depends on 1)

A micelle or micelle-like structure formed through agitation of the solid state film of claim 1, wherein the non-polar substrate and hydrophobic tail ends are sequestered in the interior of the micelle while the hydrophilic head ends are present on the outer surface of the micelle.

### Claim 13 (depends on 1)

A method for making the film of claim 1, comprising the steps of:
(a) providing a polar solvent having sufficient quantities of one or more glycosylated amphiphilic molecules dissolved therein;
(b) exposing said polar solvent to a non-polar liquid, said non-polar liquid being immiscible in said polar solvent;
(c) allowing the glycosylated amphiphilic molecules to align so as to form a membrane that separates the polar solvent from the non-polar liquid; and
(d) inducing transformation of the non-polar liquid to a corresponding non-polar solid having upper and lower surfaces, wherein the hydrophobic tail ends of the amphiphilic molecule are embedded in or chemically or mechanically linked to the upper surface of said non-polar substrate and the hydrophilic tail ends project from said upper surface into the polar solvent so as to yield a film having functional activity.

### Claim 14 (depends on 1, 13)

The method of claim 13, wherein the polar solvent is subsequently removed so as to yield a dry solid state film as defined in claim 1.

### Claim 15 (depends on 13)

The method of claim 13, wherein said transformation is a result of thermal, chemical or radiative stimulus.

### Claim 16 (depends on 13)

The method of claim 13, wherein the non-polar liquid, polar solvent and/or glycosylated amphiphilic molecules are manipulated prior to or during transition of the non-polar liquid to a solid state in order to yield a film having a geometric form.

### Claim 17 (depends on 16)

The method of claim 16, wherein said manipulation comprises the step of agitating the film so as to form micelle-like constructs.

### Claim 18 (depends on 16)

The method of claim 16, wherein the transformation of the non-polar liquid to a corresponding non-polar solid is rapidly performed so as to maintain the geometric form achieved by the non-polar liquid prior to or during the transition to a solid form.

### Claim 19 (depends on 13)

The method of claim 13, where the transformation is achieved through rapid cooling of the non-polar liquid.

### Claim 20 (depends on 1)

A method of extracting target molecules from a sample comprising the step of:
(a) exposing said sample to the solid state film of claim 1, wherein the functional groups present at the hydrophilic tail end of the glycosylated amphiphilic molecules have a binding affinity for a target molecule;
(b) allowing sufficient time for said functional groups to bind target molecules present in said sample; and
(c) removing or separating said film, to which said target molecules are bound, from said sample.

### Claim 21 (depends on 20)

The method of claim 20, wherein said target molecule is a natural or bioengineered pathogen, selected from the group consisting of microbes, viruses and toxins.

### Claim 22 (depends on 20)

The method of claim 20, wherein said target molecule comprises a heavy metal.

### Claim 23 (depends on 20)

The method of claim 20, further comprising the step of analyzing the film or a material extracted from the film for the presence of target molecule.

### Claim 24 (depends on 23)

The method of claim 23, wherein said analysis step utilizes a detection technology selected from the group consisting of PCR, immunoassays, DNA microarrays, protein microarrays, and optical recognition.

### Claim 25 (depends on 20)

The method of claim 20, further comprising the step of calculating the amount of target molecule present in the sample based on the amount of target molecule bound to the film.

### Claim 26 (depends on 20)

The method of claim 20, wherein said sample is a biological sample selected selected from the group consisting of blood, serum, saliva, sputum, urine, plasma, spinal fluid, amniotic fluid, fluids in the gastrointestinal tract, and fluids in the lungs, sweat, breast milk, tears or other lacrimal secretions, pus, and other bodily discharges associated with either normal or diseased conditions.

### Claim 27 (depends on 20)

The method of claim 20, wherein said sample comprises a continuous fluid stream and said target molecule comprises a natural or bioengineered pathogen suspected of being present in said fluid stream, further wherein said solid state film is adhered to a stream contacting surface of a vessel through which said fluid stream sample is passed.

### Claim 28 (depends on 20)

The method of claim 20, wherein the sample is subjected to a force which promotes contact between the target molecule and the membrane, said force selected from the group consisting of agitation, mechanical acceleration, centrifugal force, electrical force, magnetic force, and hydraulic force.

### Claim 29 (depends on 20)

The method of claim 20, further comprising the steps of (d) subjecting the film to which target molecules are bound to a lysing agent that effectively separates the target molecules from the film and (e) detecting the presence of separated target molecules.

### Claim 30 (depends on 1)

A method of enhancing the biocompatibility of a medical device comprising the step of coating the solid state film of claim 1 onto one or more exposed surfaces of said device.

### Claim 31 (depends on 30)

The method of claim 30, wherein said device is configured for introduction into a living biological entity.

### Claim 32 (depends on 31)

The method of claim 31, wherein said glycosylated amphiphilic molecules are recovered from an intended recipient of said medical device or an antigen-matched donor therefore.

### Claim 33

A medical device formed of or coated with a glycosylated amphiphilic membrane material having at least one functionally active surface, said membrane material comprising a substrate having upper and lower surfaces, said substrate having affixed thereto a plurality of glycosylated amphiphilic molecules, each of which comprise a hydrophobic tail end and a hydrophilic head end provided with one or more functional groups, wherein the hydrophobic tail ends are embedded in or chemically or chemically or mechanically linked to the upper surface of said non-polar substrate and the functional groups of the hydrophilic tail ends project from said upper surface so as to provide at least one surface of said film with functional activity.

### Claim 34 (depends on 33)

The medical device of claim 33 selected from the group consisting of needles, catheters, stents, shunts, tubes, wound dressings, sutures, staples, anastomosis devices, vertebral disks, bone pins, suture anchors, hemostatic barriers, clamps, screws, plates, clips, vascular implants, tissue adhesives and sealants, tissue scaffolds, bone substitutes, intraluminal devices, bone and tissue fabrication templates, and vascular supports.

### Claim 35 (depends on 33)

The medical device of claim 33, wherein said medical device is a prosthetic, artificial organ, implant or transplant material.

### Claim 36 (depends on 20)

The method of claim 20, wherein said sample is a biological sample and said steps of exposing and binding occur in vivo.

### Claim 37 (depends on 20)

The method of claim 20, wherein said sample is a biological sample and said steps of exposing and binding occur ex vivo.

### Claim 38 (depends on 36)

The method of claim 36, wherein said target molecule comprises a natural or bioengineered pathogen.
